Skip to content
Screener

USANA Health Sciences USNA Operating Cash Flow

Operating Cash Flow at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
-$1.85M-171%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$4.99M+124%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$10.63M-70.3%
Herbalife logo
HerbalifeHLF
$32.9M-65.7%
NAG
Niagen BioscienceNAGE
-$1.19M-115%
BellRing Brands logo
BellRing BrandsBRBR
-$11.2M-123%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$285.62M-50.6%
P/E14.3×+6.1×
P/S0.3×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:35 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0000896264-26-000034
Line itemThree months ended / April 4,2026Three months ended / March 29,2025
Prepaid expenses and other assets(1,689)(1,256)
Accounts payable(1,459)1,975
Other liabilities(11,945)(6,301)
Net cash provided by (used in) operating activities9,75915,482
Cash flows from investing activities
Payments for net investment hedge(1,072)
Proceeds from sale of property and equipment48
Purchases of property and equipment(2,645)(2,803)

Item 1. FINANCIAL STATEMENTS

FAQ

What is USANA Health Sciences's operating cash flow?
USANA Health Sciences (USNA) reported operating cash flow of $9.76M in Q1 2026.
How has USANA Health Sciences's operating cash flow changed year-over-year?
USANA Health Sciences's operating cash flow decreased by 37.0% year-over-year, from $15.48M to $9.76M.
What is the long-term trend for USANA Health Sciences's operating cash flow?
Over 3 years (2021 to 2024), USANA Health Sciences's operating cash flow has grown at a -20.5% compound annual growth rate (CAGR), from $121.23M to $60.99M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about USANA Health Sciences's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude